Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+T Cell Response by Preventing Type I IFN–Dependent Depletion of Dendritic Cells-Reference-Cited by-同舟云学术

Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+T Cell Response by Preventing Type I IFN–Dependent Depletion of Dendritic Cells

Published:2016-11-21 Issue:1 Volume:198 Page:383-393
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Loo Christopher P.^ORCID,Snyder Christopher M.^ORCID,Hill Ann B.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference53 articles.

1. Sustained CD8+ T Cell Memory Inflation after Infection with a Single-Cycle Cytomegalovirus

2. What messenger RNA capping tells us about eukaryotic evolution

3. CD8+ T cell contraction is controlled by early inflammation

4. Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus

5. Self MHC class I–licensed NK cells enhance adaptive CD8 T-cell viral immunity

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How dendritic cells sense and respond to viral infections;Clinical Science;2021-10

2. Optimal CD8 + T‐cell memory formation following subcutaneous cytomegalovirus infection requires virus replication but not early dendritic cell responses;Immunology;2021-06-13

3. Optimal CD8+ T-cell memory formation following subcutaneous cytomegalovirus infection requires virus replication but not early dendritic cell responses;2020-12-02

4. Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity;Science Translational Medicine;2019-07-17

5. Atomic structures and deletion mutant reveal different capsid-binding patterns and functional significance of tegument protein pp150 in murine and human cytomegaloviruses with implications for therapeutic development;PLOS Pathogens;2019-02-19